Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
ID07219680

Intervention to Promote Communication Quality of Life for Persons With Language-Led Dementia and Their Partners: A Randomized Pilot Trial

Led by Maya Henry · Updated on 2026-04-21

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Maya Henry

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a personalized, multi-component virtual speech language treatment program designed to improve communication and quality of life for adults with primary progressive aphasia (PPA) and their main communication partners. The study focuses on the feasibility, acceptability, and benefits of this telerehabilitation program, comparing immediate treatment to a waitlist control group. The trial includes English and/or Spanish speakers and aims to identify useful outcome measures and patterns of treatment response. Participants will receive speech language therapy sessions delivered by video that combine restorative, compensatory, and partner-focused communication strategies. Those in the waitlist control group will have an initial assessment followed by a 12 or 13-week waiting period before treatment begins. The immediate treatment group will start therapy right after assessment. Treatments include two specific multi-component programs: Multicomponent Lexical Retrieval Cascade Training and Multicomponent Video Implemented Script Training in Aphasia, both involving clinician-led sessions and independent practice alongside communication counseling with a study partner. During the study, participants and their partners will complete speech, language, and cognitive assessments, as well as questionnaires about communication abilities, daily functioning, and quality of life. Researchers will measure changes in spoken naming, script production accuracy, dyad conversation, and communication modality, along with secondary measures like aphasia impact and caregiver quality of life. Follow-up assessments occur three months post-treatment to monitor outcomes and participant experiences throughout the trial.

CONDITIONS

Brief Title

Intervention for Communication Quality of Life in Primary Progressive Aphasia

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of primary progressive aphasia (PPA) or PPA-plus
  • MMSE score of 15 or higher and ability to produce single monosyllabic words intelligibly
  • Speaks English, Spanish, or both languages
  • Hearing and vision adequate for teleconference participation
  • Has a study partner who can attend teleconference sessions
  • Study partner willing to participate in assessments and treatment sessions
  • Study partner speaks English, Spanish, or both languages
  • Study partner's hearing and vision adequate for teleconference participation
  • Participant and/or study partner has basic computer experience
Not Eligible

You will not qualify if you...

  • Other central nervous system or medical diagnosis that explains symptoms
  • Psychiatric diagnosis that explains symptoms

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Treatment

Duration - 12 to 13 weeks

Participants receive behavioral interventions via in-person or teletherapy sessions, including biweekly sessions with a clinician targeting communication skills and strategy use, along with daily independent practice and meetings with a study partner for communication counseling and education.

Biweekly clinician sessions and 6 communication counseling sessions with a study partner

Follow-up

Duration - 3 months post-treatment

Participants are monitored for changes in communication abilities and quality of life after treatment completion.

1 follow-up visit

Trial Site Locations

Total: 1 location

1

University of Texas

Austin, Texas, United States, 78712

Actively Recruiting

Loading map...

Research Team

H

Henry Lab Research Coordinator

G

Grasso Lab Research Coordinator

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration...

Frontotemporal Lobar Degeneration (FTLD)

Actively Recruiting

27 locations

A Phase 2a Clinical Study of the P38 Alpha Kinase Inhibitor ...

Nonfluent Variant Primary Progressive Aphasia (nfvPPA)

Actively Recruiting

7 locations

Multimodal Assessment for Predicting Specific Pathological S...

Corticobasal Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Treatment for Word Retrieval in Semantic and Logopenic Variants of Primary Progressive Aphasia: Immediate and Long-Term Outcomes.

Maya L Henry, H Isabel Hubbard, Stephanie M Grasso...

https://pubmed.ncbi.nlm.nih.gov/31390290